TP53 and neoplasm: Notably, p533KR, an acetylation-defective p53 mutant that fails to induce cell cycle arrest, apoptosis, and senescence, still exhibits tumor suppression by binding the promoter of the SLC7A11 gene to active ferroptosis (Fig. 1) [44].